Promising Antitumor Activity After One ADC Dose in Breast Cancer
Early data suggest that the antibody drug conjugate patritumab deruxtecan increases antitumor activity in early-stage breast cancer after a single dose.
Stay updated with breaking news from Biomedical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Early data suggest that the antibody drug conjugate patritumab deruxtecan increases antitumor activity in early-stage breast cancer after a single dose.
Dr Eric Topol sits down with Mark Zuckerberg and Priscilla Chan to talk about the next phase of their ambitious Chan Zuckerberg Initiative.
HSINCHU, April 25, 2022 /PRNewswire/ -- The Edison Awards, one of the world's most revered innovation awards, announced the 2022 winners on April ...
Taipei, April 25 (CNA) Taiwan's Industrial Technology Research Institute (ITRI) won two medals for medical innovations at the recent Edison Awards, which honor innovative products and solutions in a range of fields such as tech, education, and science.
/PRNewswire/ -- The Edison Awards, one of the world's most revered innovation awards, announced the 2022 winners on April 21 in Fort Myers, FL. At this year's...